Raffa Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$221 Hold
2
– – ﹤0.01% 1271
2026
Q2
$157 Buy
2
+1
+100% +$68 ﹤0.01% 1299
2026
Q1
$65 Buy
+1
New +$70 ﹤0.01% 1363
2022
Q4
– Sell
-33
Closed -$1.3K – 1105
2022
Q3
$1.3K Hold
33
– – ﹤0.01% 718
2022
Q2
$1.45K Hold
33
– – ﹤0.01% 693
2022
Q1
$1.32K Hold
33
– – ﹤0.01% 761
2021
Q4
$1.33K Hold
33
– – ﹤0.01% 778
2021
Q3
$1.34K Hold
33
– – ﹤0.01% 727
2021
Q2
$1.5K Hold
33
– – ﹤0.01% 705
2021
Q1
$1.38K Hold
33
– – ﹤0.01% 740
2020
Q4
$1.41K Hold
33
– – ﹤0.01% 646
2020
Q3
$867 Buy
33
+11
+50% +$306 ﹤0.01% 711
2020
Q2
$590 Buy
22
+8
+57% +$180 ﹤0.01% 784
2020
Q1
$252 Buy
+14
New +$266 ﹤0.01% 824

Other funds holding HALO

Raffa Wealth Management's HALO Position: Q3 2026 in Review

Raffa Wealth Management held its Halozyme (HALO) position steady in Q3 2026 at 2 shares worth $221. The position accounts for ﹤0.01% of the portfolio, ranked #1271.

Raffa Wealth Management first reported a position in HALO in Q1 2020 and has held it in 14 quarters since. The position peaked at $1.5K in Q2 2021. 774 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Raffa Wealth Management held 2 shares of Halozyme worth $221 as of Q3 2026.
  • Raffa Wealth Management left its Halozyme share count unchanged in Q3 2026.
  • Halozyme made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1271 holding.
  • Raffa Wealth Management first reported a position in Halozyme in Q1 2020 and has held it in 14 quarters since.
  • Raffa Wealth Management's Halozyme position peaked at $1.5K in Q2 2021.
  • 774 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.